GE LOGIQ V5/LOGIQ V3
D
IRECTION 5496012-100, REVISION 3BASIC SERVICE MANUAL
8 - 2  - 
Section 8-2 DISASSEMBLY/RE-ASSEMBLY
8-2-1 Warning and Caution  
8-2-2 Returning/Shipping for repairs
Equipment being returned must be clean and free of blood and other infectious substances.
GE policy states that body fluids must be properly removed from any part or equipment prior to 
shipment. GE employees, as well as customers, are responsible for ensuring that parts/equipment have 
been properly decontaminated prior to shipment. Under no circumstance should a part or equipment 
with visible body fluids be taken or shipped from a clinic or site (for example, body coils or an ultrasound 
probe). The purpose of the regulation is to protect employees in the transportation industry, as well as 
the people who will receive or open this package.
NOTE: The US Department of Transportation (DOT) has ruled that “items that were saturated and/or 
dripping with human blood that are now caked with dried blood; or which were used or intended 
for use in patient care” are “regulated medical waste” for transportation purposes and must be 
transported as a hazardous material.
If the LOGIQ V5/LOGIQ V3 needs to be sent for repair, ensure that any patient information is erased 
from the Harddisk/Storage Device. In case that any patient information is still residing on the LOGIQ V5/
LOGIQ V3, GE will contact the customer and request for urgent collection of that patient information. 
GE will keep this patient information in a secure environment for a maximum period of 1 month. All 
patient information will be permanently deleted at that point.
If PHI (Patient Healthcare Information) data needs to be sent to GE employees for service purposes, 
GE will ascertain agreement from the customer. The paitent information shall only be transferred by 
approved service processes, tools and devices restricting access, protecting or encrypting data where 
required, and providing traceability in the form of paper or electronic documents at each stage of the 
procedure while maintaining compliance with cross-border restrictions of patient information transfers.